Nasef, Sherif A.; Shaaban, A. Aziz; Mould-Quevedo, Joaquin - In: Health economics review 5 (2015) 13, pp. 1-8
Background: Cyclooxygenase (COX)-2 inhibitors including celecoxib are as effective as non-selective non-steroidal anti-inflammatory drugs (ns-NSAIDs) in the treatment of osteoarthritis (OA) and have less gastrointestinal toxicity. Although they are associated with higher treatment costs, COX-2...
